Daehan New Pharm Co., Ltd. (KOSDAQ:A054670) agreed to acquired additional 3.5% stake in Baverstock GmbH from Kuat Rafikly Oraziman for KRW 5.6 billion on November 23, 2016. Daehan New Pharm Co., Ltd will acquire additional 1,000 shares and will hold 30% stake equivalent to 6,000 shares in Baverstock GmbH after the closing of the transaction. 1.5% stake will be acquired as consideration for the sale of equity in BNG ENERGY B.V. The consideration for 3.5% stake will be funded through borrowings. Baverstock GmbH reported total assets of KRW 6.1 billion, revenues of KRW 219 million and net profit of KRW 162 million in the year ended December 31, 2015. The transaction is expected to close on November 23, 2016. On November 23, 2016, the scheduled acquisition date has been changed to February 23, 2017. Daehan New Pharm Co., Ltd. (KOSDAQ:A054670) cancelled the acquisition of additional 3.5% stake in Baverstock GmbH from Kuat Rafikly Oraziman on November 23, 2017.